Clinical effectiveness of nanogel of Acorus calamus and Butea monosperma with Carbamazepine in the treatment of trigeminal neuralgia-A clinical trial

Comparison,Formulation,Characterisation and Clinical effectiveness of nanogel of Acorus calamus and Butea monosperma with Carbamazepine in the treatment of trigeminal neuralgia-A clinical trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109195

Enrollment

Registered

2026-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G968- Other specified disorders of central nervous system

Interventions

Intervention1: Acorus calamus with carbamazepine, Butea monosoperma with carbamazepine: Acorus calamus and Butea monosperma are herbal plants that have neuroprotective properties similar to carbamazep

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Trigeminal neuralgia

Exclusion criteria

Exclusion criteria: TMDs Other neuralgias

Design outcomes

Primary

Measure	Time frame
Reduction in the pain intensityTimepoint: Reduction in the pain intensity	—

Secondary

Measure	Time frame
Improving the QOL Assess Pre and post treatment phasesTimepoint:	—

Countries

India

Contacts

Public ContactSelva sigamani V

Saveetha dental college

152310003.sdc@saveetha.com06382125228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026